Abaloparatide FAQs

What is abaloparatide? 

Its brand name is Eladynos (Tymlos in the US). It’s an osteoporosis drug treatment that strengthens bones and makes them less likely to break, administered via a small daily injection which you give yourself, just under the skin, for 18 months. You would usually be prescribed another type of osteoporosis medication to follow on from this after the 18 months.

Who is it for? 

It’s recommended by NICE for those with a ‘very high risk’ of fracture. This means those who have ‘many risk factors for fracture’. It will be offered to you mainly if you have had spinal fractures or continue to have broken bones despite taking another drug treatment.

Can men have abaloparatide?

Abaloparatide is currently licensed for post-menopausal women. There isn’t much research yet on its use for men, although it’s likely to be effective. It isn’t yet licensed or approved for men or pre-menopausal women.

Is it better at strengthening bones than other osteoporosis drug treatments?

Abaloparatide is one of the three drugs now available that has an anabolic effect. The other drugs are teriparatide and romosozumab. Anabolic means they stimulate the cells that build bone, so they may be the best drugs for those with the highest risk of fracture. This is called a ‘very high fracture risk’. Most osteoporosis drugs, like bisphosphonates, work by slowing down the cells that break down bone. These drugs work well for most people. 

How does abaloparatide compare to teriparatide?

The two drugs are very similar and are likely to have the same benefits for bones, as well as similar possible side effects. You can read more about teriparatide here.

Is it available in all nations in the UK?

It will become available in England, Wales and Northern Ireland over the next few months. It is likely to be considered for approval in Scotland early next year.

Can my GP prescribe it? 

No, you would need to see a hospital specialist. 

How can I find out if abaloparatide is right for me?

There’s no urgency, but you can discuss this with your doctor or other health care professional if you think that you may need a treatment, or when your current drug treatment is reviewed. Your doctor or health care professional will discuss your fracture risk and help decide what treatment will suit you best.

How can I find out more?

We will be producing more information about abaloparatide when it becomes available.